Next Generation Multipurpose Prevention Technologies (NGM) (R01)

The objective of this grant is to support the development of new and innovative on-demand, event -driven and long-acting systemic and non-systemic multipurpose prevention technologies (MPT). 

It supports development of MPTs that prevent HIV infection and pregnancy (hormonal and non-hormonal methods); sexually transmitted infections (STI) and pregnancy, and (HIV/STI) and non-HIV STI MPTs in cis and trans males and females of all ages. Applications for MPT development may involve pharmacokinetic (PK), pharmacodynamic (PD), safety and, drug-drug interactions (DDI) studies using drug development and formulation science supported by animal model testing. 

Funding: No fixed limit 

Duration: 5 years 

Research Authority due date: 10 days prior to submission 

LOI (encouraged) due dates: 7.11.22, 7.11.23, 7.11.24

Full proposal due dates: 7.12.22, 7.12.23, 7.12.24